Rieneke van de Ven - Concepedia

Author

Rieneke van de Ven

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

R van de Ven, R. Ven, R. van de Ven, Rieneke Van De Ven, Rieneke Van de Ven, Rieneke van de Ven

166

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam University Medical Centers Vrije Universiteit Amsterdam Cancer Center Amsterdam The Netherlands Cancer Institute

About

Rieneke van de Ven is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	238
2	Immunology	8	8	238
3	Cell Biology	7	7	224
4	Autoimmune Disease	3	3	65
5	Allergy	1	1	16

Rieneke van de Ven

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation Rieneke van de Ven, Mari F.C.M. van den Hout, Jelle J. Lindenberg, Blood	2011	91
Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination Sophie K. Horrevorts, Dorian A. Stolk, Rieneke van de Ven, Cancers	2019	90
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node Kim M. van Pul, Ronald J.C.L.M. Vuylsteke, Rieneke van de Ven, Journal for ImmunoTherapy of Cancer	2019	64
Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation Rieneke van de Ven, Mariska C. de Jong, Anneke W. Reurs, The Journal of Immunology	2006	62
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma Jason R. Baird, R. Bryan Bell, Victoria Troesch, Cancer Research	2018	62
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster, Cancer Immunology Research	2015	61
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition Dinja Oosterhoff, Sinéad M. Lougheed, Rieneke van de Ven, OncoImmunology Jak2/stat3 PathwayImmunologyImmunoeditingImmunologic MechanismTumor-mediated Inhibition	2012	59
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration Rieneke van de Ven, George L. Scheffer, Anneke W. Reurs, Blood	2008	55
Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche Kevin Kos, Muhammad Assad Aslam, Rieneke van de Ven, Cell Reports Cancer ImmunosurveillanceMedicineT-regulatory CellImmunologyTumor Immunity	2022	52
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence Mari F.C.M. van den Hout, Bas D. Koster, Berbel J.R. Sluijter, Cancer Immunology Research	2017	50

Page 1